Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. 25762808 Guertin KA, Loftfield E, Boca SM, Sampson JN, Moore SC, Xiao Q, Huang WY, Xiong X, Freedman ND, Cross AJ, Sinha R Am. J. Clin. Nutr. 2015 PLCO
Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. 25731953 Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P, Breast and Prostate Cancer Cohort Consortium Group Cancer 2015 PLCO
Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. 25515550 Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsso… Cancer Epidemiol. Biomarkers Prev. 2015 PLCO
Physical Activity and Risk of Male Breast Cancer. 26404962 Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE Cancer Epidemiol. Biomarkers Prev. 2015 PLCO
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. 25964249 Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB J. Clin. Oncol. 2015 PLCO
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. 26391917 Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane-Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci E, Graubard BI, Hollenbeck AR, Hou L, Jacobs EJ, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, Purdu… Cancer Prev Res (Phila) 2015 PLCO
Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. 26126626 Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, Alavanja MC, Beane-Freeman LE, Boggs DA, Buring JE, Chan AT, Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, Hollenbeck AR, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, … Cancer Epidemiol. Biomarkers Prev. 2015 PLCO
Polybrominated diphenyl ethers and thyroid cancer risk in the Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial cohort. 25939348 Aschebrook-Kilfoy B, DellaValle CT, Purdue M, Kim C, Zhang Y, Sjodin A, Ward MH American journal of epidemiology 2015 PLCO
Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. 25293880 Kim C, Bassig BA, Seow WJ, Hu W, Purdue MP, Huang WY, Liu CS, Cheng WL, Männistö S, Vermeulen R, Weinstein SJ, Lim U, Hosgood HD, Bonner MR, Caporaso NE, Albanes D, Lan Q, Rothman N Cancer Epidemiol Biomarkers Prev 2015 PLCO
Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood. 25549806 Hirt C, Camargo MC, Yu KJ, Hewitt SM, Dölken G, Rabkin CS Leuk Lymphoma 2015 PLCO
Vitamin D-binding protein and pancreatic cancer: a nested case-control study. 25904602 Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ Am J Clin Nutr 2015 PLCO
A prospective evaluation of C-peptide levels and colorectal adenoma incidence. 25592235 Murphy N, Cross AJ, Huang WY, Rajabzadeh-Heshejin V, Stanczyk F, Hayes R, Gunter MJ Cancer Epidemiol 2015 PLCO
Genome-wide association study of survival in patients with pancreatic adenocarcinoma. 23180869 Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F… Gut 2014 PLCO
LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. 24316677 Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE Epigenetics 2014 PLCO
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. 24053621 Pinsky PF, Parnes HL, Andriole G BJU Int. 2014 PLCO
Body mass index and mortality among blacks and whites adults in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. 23512729 Xiao Q, Hsing AW, Park Y, Moore SC, Matthews CE, Berrington de González A, Kitahara CM Obesity (Silver Spring) 2014 PLCO
Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. 25192282 O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA PLoS ONE 2014 NLST, PLCO
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. 25044253 Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y Urol. Oncol. 2014 NLST, PLCO
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. 24577803 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK Cancer 2014 NLST, PLCO
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. 25460915 Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD PLoS Med. 2014 NLST, PLCO